260 related articles for article (PubMed ID: 16723304)
1. Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.
Georgopoulos NA; Adonakis GL; Fotopoulos A; Koika V; Spinos N; Saltamavros A; Keramopoulos A; Koukouras D; Decavalas G; Kourounis GS
Gynecol Endocrinol; 2006 Apr; 22(4):185-9. PubMed ID: 16723304
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
4. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome.
Frasor J; Chang EC; Komm B; Lin CY; Vega VB; Liu ET; Miller LD; Smeds J; Bergh J; Katzenellenbogen BS
Cancer Res; 2006 Jul; 66(14):7334-40. PubMed ID: 16849584
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival.
Boyapati SM; Shu XO; Ruan ZX; Cai Q; Smith JR; Wen W; Gao YT; Zheng W
Clin Cancer Res; 2005 Feb; 11(3):1093-8. PubMed ID: 15709176
[TBL] [Abstract][Full Text] [Related]
7. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
Shen Y; Li DK; Wu J; Zhang Z; Gao E
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
[TBL] [Abstract][Full Text] [Related]
8. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G
J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459
[TBL] [Abstract][Full Text] [Related]
9. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
[TBL] [Abstract][Full Text] [Related]
10. Association of estrogen receptor alpha (ERα) gene polymorphisms with endometrial thickness and lipid profile in women with breast cancer treated with aromatase inhibitors.
Koukouras D; Marioli DJ; Papadopoulos K; Adonakis GL; Armeni AK; Georgopoulos NA; Decavalas G
Gynecol Endocrinol; 2012 Nov; 28(11):859-62. PubMed ID: 22799738
[TBL] [Abstract][Full Text] [Related]
11. The estrogen receptor alpha gene and breast cancer risk (The Netherlands).
Onland-Moret NC; van Gils CH; Roest M; Grobbee DE; Peeters PH
Cancer Causes Control; 2005 Dec; 16(10):1195-202. PubMed ID: 16215870
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study.
Cai Q; Shu XO; Jin F; Dai Q; Wen W; Cheng JR; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):853-9. PubMed ID: 14504194
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.
Saadat M; Truong PT; Kader HA; Speers CH; Berthelet E; McMurtrie E; Olivotto IA
Cancer; 2007 Jul; 110(1):31-7. PubMed ID: 17510927
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
15. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
[TBL] [Abstract][Full Text] [Related]
16. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.
Wu H; Chen Y; Liang J; Shi B; Wu G; Zhang Y; Wang D; Li R; Yi X; Zhang H; Sun L; Shang Y
Nature; 2005 Dec; 438(7070):981-7. PubMed ID: 16355216
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
[TBL] [Abstract][Full Text] [Related]
19. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
20. Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer.
Owusu C; Buist DS; Field TS; Lash TL; Thwin SS; Geiger AM; Quinn VP; Frost F; Prout M; Yood MU; Wei F; Silliman RA
J Clin Oncol; 2008 Feb; 26(4):549-55. PubMed ID: 18071188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
